Brianne Jahn - 29 Oct 2021 Form 3 Insider Report for LianBio (LIANY)

Role
Chief Business Officer
Signature
By /s/ Angela Chen, Attorney-in-Fact
Issuer symbol
LIANY
Transactions as of
29 Oct 2021
Net transactions value
$0
Form type
3
Filing time
29 Oct 2021, 18:10:29 UTC
Next filing
01 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LIAN Stock Option (Right to Buy) 29 Oct 2021 Ordinary Shares 584,780 $6.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3 of the shares underlying the option vested and became exercisable on February 1, 2021; the remainder shall vest and become exercisable in 2 equal annual installments such that the option shall be fully vested on February 1, 2023, subject to the Reporting Person providing continuous service to the Issuer on each such date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney